French biotech firm Vectalys has received a license to use a technology developed by Kyoto University in the production of induced pluripotent stem cells. Vectalys plans to market iPS cell-producing kits that also incorporate its gene-delivery technology.
Kyoto University licenses biotech firm to use stem cell method
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|